Product NDC: | 60760-322 |
Proprietary Name: | Kadian ER |
Non Proprietary Name: | MORPHINE SULFATE |
Active Ingredient(s): | 20 mg/1 & nbsp; MORPHINE SULFATE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60760-322 |
Labeler Name: | St Marys Medical Park Pharmacy |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020616 |
Marketing Category: | NDA |
Start Marketing Date: | 20101221 |
Package NDC: | 60760-322-30 |
Package Description: | 30 CAPSULE in 1 BOTTLE (60760-322-30) |
NDC Code | 60760-322-30 |
Proprietary Name | Kadian ER |
Package Description | 30 CAPSULE in 1 BOTTLE (60760-322-30) |
Product NDC | 60760-322 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MORPHINE SULFATE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20101221 |
Marketing Category Name | NDA |
Labeler Name | St Marys Medical Park Pharmacy |
Substance Name | MORPHINE SULFATE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |